2 enrolling by invitation. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Enrolling by invitation 2 |
| Phase 2 | 2 | Enrolling by invitation 2 |
Follow Keratoconus: new trials by email Literature Review of Keratoconus trials Research Report on Keratoconus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of TN-001 Topical Eyedrops for Keratoconus Low-dose TGF-B3 and Dexamethasone Sodium Phosphate, High-dose TGF-B3 and Dexamethasone Sodium Phosphate - Keratoconus | Phase 1 / Phase 2 | Enrolling by invitation | TheiaNova Ltd. | 20 | 2025-12-23 | 2026-02-04 |
| Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking Dextenza 0.4Mg Ophthalmic Insert, topical prednisolone acetate 1% (PredForte) eye drops - Keratoconus | Phase 1 / Phase 2 | Enrolling by invitation | Maanasa Indaram, MD | 20 | 2025-04-11 | 2026-09-11 |
Corneal Diseases (2) · Eye Diseases (2)
Calcium Dobesilate (1) · Ophthalmic Solutions (1) · dexamethasone 21-phosphate (1) · prednisolone acetate (1)
Maanasa Indaram, MD (1) · TheiaNova Ltd. (1)
Australia (1) · United States (1)